| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
1992-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a65129874630172ab6864f2a72460668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c45e6f8bcb0d43f681e38eed937b229d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4721fc91c6fcb34fdf9fecc91fc42d70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6acbe36e5a170973fe919a9d6bde6a41 |
| publicationDate |
1994-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0600018-A1 |
| titleOfInvention |
Hepatitis c assay utilizing recombinant antigens to c-100 region |
| abstract |
The present invention provides unique recombinant antigens representing distinct antigenic regions of the hepatitis C virus (HCV) genome which can be used as reagents for the detection of antibodies and antigen in body fluids. from individuals who have been exposed to the hepatitis C virus. The present invention also relates to a method for detecting the presence of an antibody directed against an HCV antigen, in a sample, said method consisting in bringing into contact the sample with the recombinant antigens. Preferred types of methods include a triage method, a confirmation method, a comparison or neutralization method, and a point deposit immunoassay method. |
| priorityDate |
1991-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |